Predictors of tolvaptan short‐term response in patients with refractory ascites: A meta‐analysis

Background and Aim Tolvaptan represents an oral V2‐receptor antagonist, which has been suggested as a promising add‐on diuretic treatment for refractory ascites. The present meta‐analysis aims to accumulate current evidence and identify which clinical and laboratory factors are linked to short‐term...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of gastroenterology and hepatology 2020-02, Vol.35 (2), p.182-191
Hauptverfasser:	Bellos, Ioannis, Kontzoglou, Konstantinos, Perrea, Despina N
Format:	Artikel
Sprache:	eng
Schlagworte:	Ascites Body weight cirrhosis Clinical trials Creatinine Diuretics Hepatitis Hepatitis C Meta-analysis Patients Proteins response tolvaptan Urea
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!